Abstract
Products of metabolism accumulate in kidney failure and potentially have toxic effects. Traditionally these uraemic toxins are classified as small, middle-sized and protein-bound toxins, and clearance during dialysis is affected by diffusion, convection and adsorption. As current dialysis practice effectively clears small solutes, increasing evidence supports a toxic effect for middle-sized and protein-bound toxins. Therefore, newer approaches to standard dialysis practice are required to look beyond urea clearance. Current dialysers have been developed to effectively clear small solutes and secondly to increase middle-sized toxin clearances. However, there is no ideal dialyser which can effectively clear all uraemic toxins. Advances in nanotechnology have led to improvements in manufacturing, with the production of smoother membrane surfaces and uniformity of pore size. The introduction of haemodiafiltration has led to changes in dialyser design to improve convective clearances. Both diffusional and convectional clearances can be increased by changing dialyser designs to alter blood and dialysate flows, and novel dialyser designs using microfluidics offer more efficient solute clearances. Adjusting surface hydrophilicity and charge alter adsorptive properties, and greater clearance of protein-bound toxins can be achieved by adding carbon or other absorptive monoliths into the circuit or by developing composite dialyser membranes. Other strategies to increase protein-bound toxins clearances have centred on disrupting binding and so displacing toxins from proteins. Just as the hollow fibre design replaced the flat plate dialyser, we are now entering a new era of dialyser designs aimed to increase the spectrum of uraemic toxins which can be cleared by dialysis.
Similar content being viewed by others
References
Twardowski ZJ (2008) History of hemodialyzers’ designs. Hemodial Int 12:173–210
Ronco C, Brendolan A, Everard P, Irone M, Ballestri M, Cappelli G, Inguaggiato P, Bellomo R (1999) Cellulose triacetate: another membrane for continuous renal replacement therapy. J Nephrol 12:241–247
Ronco C, Brendolan A, Crepaldi C, Rodighiero M, Scabardi M (2002) Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. J Am Soc Nephrol 13[Suppl 1]:S53–S61
Shibata E, Nagai K, Takeuchi R, Noda Y, Makino T, Chikata Y, Hann M, Yoshimoto S, Ono H, Ueda S, Tamaki M, Murakami T, Matsuura M, Abe H, Doi T (2015) Re-evaluation of pre-pump arterial pressure to avoid inadequate dialysis and hemolysis: importance of prepump arterial pressure monitoring in hemodialysis patients. Artif Organs 39:627–634
Asano M, Thumma J, Oguchi K, Pisoni RL, Akizawa T, Akiba T, Fukuhara S, Kurokawa K, Ethier J, Saran R, Saito A, Group JDR (2013) Vascular access care and treatment practices associated with outcomes of arteriovenous fistula: international comparisons from the Dialysis Outcomes and Practice Patterns Study. Nephron Clin Pract 124:23–30
Ferraro B, Galli F, Frei B, Kingdon E, Canestrari F, Rice-Evans C, Buoncristiani U, Davenport A, Moore KP (2003) Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients. Kidney Int 63:2207–2213
Davenport A (2014) How can dialyzer designs improve solute clearances for hemodialysis patients? Hemodial Int Suppl 1:S43–S47
Lim H-C, Lee S-J (2004) Flow control of a circular cylinder with O-rings. Fluid Dyn Res 35:107–122
Ronco C, Bowry SK, Brendolan A, Crepaldi C, Soffiati G, Fortunato A, Bordoni V, Granziero A, Torsello G, La Greca G (2002) Hemodialyzer: from macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers. Kidney Int Suppl 80:126–142
Hirano A, Yamamoto K, Matsuda M, Ogawa T, Yakushiji T, Miyasaka T, Sakai K (2011) Evaluation of dialyzer jacket structure and hollow-fiber dialysis membranes to achieve high dialysis performance. Ther Apher Dial 15:66–74
Yamamoto K, Matsuda M, Hirano A, Takizawa N, Iwashima S, Yakushiji T, Fukuda M, Miyasaka T, Sakai K (2009) Computational evaluation of dialysis fluid flow in dialyzers with variously designed jackets. Artif Organs 33:481–486
Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G (2006) Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17:546–555
Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis Study G (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. New Engl J Med 347:2010–2019
Sakai K, Matsuda M (2011) Solute removal efficiency and biocompatibility of the high-performance membrane - from engineering points of view. Contrib Nephrol 173:11–22
Naka T, Haase M, Bellomo R (2010) ‘Super high-flux’ or ‘high cut-off’ hemofiltration and hemodialysis. Contrib Nephrol 166:181–189
Buus NH, Rantanen JM, Krag SP, Andersen NF, Jensen JD (2015) Hemodialysis using high cut off filters in light chain cast nephropathy. Blood Purif 40:223–231
Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D (2012) Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrol Dial Transplant 27:3823–3828
Premru V, Kovac J, Buturovic-Ponikvar J, Ponikvar R (2013) Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure. Ther Apher Dial 17:396–401
Kneis C, Beck W, Boenisch O, Klefisch F, Deppisch R, Zickler D, Schindler R (2013) Elimination of middle-sized uremic solutes with high-flux and high-cut-off membranes: a randomized in vivo study. Blood Purif 36:287–294
Girndt M, Fiedler R, Martus P, Pawlak M, Storr M, Bohler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Zickler D, Schindler R (2015) High cut-off dialysis in chronic haemodialysis patients. Eur J Clin Invest 45:1333–1340
Krieter DH, Canaud B (2003) High permeability of dialysis membranes: what is the limit of albumin loss? Nephrol Dial Transplant 18:651–654
Ronco C, Orlandini G, Brendolan A, Lupi A, La Greca G (1998) Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer: technical note. Kidney Int 54:979–985
Hasegawa T, Nakai S, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y, Akizawa T (2015) Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. Am J Kidney Dis 65:899–904
Ledebo I (2004) Ultrapure dialysis fluid: improving conventional and daily dialysis. Hemodial Int Int Symp Home Hemodial 8:159–166
Ronco C, Brendolan A, Lupi A, Metry G, Levin NW (2000) Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 58:809–817
Davenport A, Peters SA, Bots ML, Canaud B, Grooteman MP, Asci G, Locatelli F, Maduell F, Morena M, Nube MJ, Ok E, Torres F, Woodward M, Blankestijn PJ, Investigators HDFPP (2016) Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size. Kidney Int 89:193–199
Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A, Group ES (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24:487–497
Maduell F, Arias-Guillen M, Fontsere N, Ojeda R, Rico N, Vera M, Elena M, Bedini JL, Wieneke P, Campistol JM (2014) Elimination of large uremic toxins by a dialyzer specifically designed for high-volume convective therapies. Blood Purif 37:125–130
Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R (2009) Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 24:562–570
Davenport A (2008) Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure. Int J Artif Organs 31:3–5
Kumar S, Khosravi M, Massart A, Potluri M, Davenport A (2013) Haemodiafiltration results in similar changes in intracellular water and extracellular water compared to cooled haemodialysis. Am J Nephrol 37:320–324
Lee KH, Kim DJ, Min BG, Lee SH (2007) Polymeric nanofiber web-based artificial renal microfluidic chip. Biomed Microdevices 9:435–442
Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P (2008) Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73:1174–1180
Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y (2006) Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69:1081–1087
Kandouz S, Mohamed AS, Zheng Y, Sandeman S, Davenport A (2016) Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration. Hemodial Int 20:610–617
Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, Wanner C, Canaud B (2010) Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 25:212–218
Sirich TL, Luo FJ, Plummer NS, Hostetter TH, Meyer TW (2012) Selectively increasing the clearance of protein-bound uremic solutes. Nephrol Dial Transplant 27:1574–1579
Luo FJ, Patel KP, Marquez IO, Plummer NS, Hostetter TH, Meyer TW (2009) Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial. Am J Kidney Dis 53:1042–1049
De Smet R, Dhondt A, Eloot S, Galli F, Waterloos MA, Vanholder R (2007) Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes. Nephrol Dial Transplant 22:2006–2012
Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS, Group FHNT (2013) Effect of frequent hemodialysis on residual kidney function. Kidney Int 83:949–958
Krieter DH, Devine E, Korner T, Ruth M, Wanner C, Raine M, Jankowski J, Lemke HD (2017) Haemodiafiltration at increased plasma ionic strength for improved protein-bound toxin removal. Acta Physiol 219:510–520
Tao X, Thijssen S, Kotanko P, Ho CH, Henrie M, Stroup E, Handelman G (2016) Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study. Sci Rep 6:23389
Hirsh SL, McKenzie DR, Nosworthy NJ, Denman JA, Sezerman OU, Bilek MM (2013) The Vroman effect: competitive protein exchange with dynamic multilayer protein aggregates. Colloids Surf B Biointerfaces 103:395–404
Clark WR, Macias WL, Molitoris BA, Wang NH (1995) Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 48:481–488
Tessitore N, Lapolla A, Arico NC, Poli A, Gammaro L, Bassi A, Bedogna V, Corgnati A, Reitano R, Fedele D, Lupo A (2004) Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels. J Nephrol 17:707–714
Galli F, Benedetti S, Buoncristiani U, Piroddi M, Conte C, Canestrari F, Buoncristiani E, Floridi A (2003) The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Kidney Int 64:748–755
Ronco C, Brendolan A, Winchester JF, Golds E, Clemmer J, Polaschegg HD, Muller TE, La Greca G, Levin NW (2001) First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis. Blood Purif 19:260–263
Meyer TW, Peattie JW, Miller JD, Dinh DC, Recht NS, Walther JL, Hostetter TH (2007) Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 18:868–874
Sandeman SR, Howell CA, Phillips GJ, Zheng Y, Standen G, Pletzenauer R, Davenport A, Basnayake K, Boyd O, Holt S, Mikhalovsky SV (2014) An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. J Mater Sci Mater Med 25:1589–1597
Tijink MS, Wester M, Glorieux G, Gerritsen KG, Sun J, Swart PC, Borneman Z, Wessling M, Vanholder R, Joles JA, Stamatialis D (2013) Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma) Biomaterials 34:7819–7828
Betjes MG, Hoekstra FM, Klepper M, Postma SM, Vaessen LM (2004) Vitamin E-coated dialyzer membranes downregulate expression of monocyte adhesion and co-stimulatory molecules. Blood Purif 22:510–517
Yang SK, Xiao L, Xu B, Xu XX, Liu FY, Sun L (2014) Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis. Renal Fail 36:722–731
Islam MS, Hassan ZA, Chalmin F, Vido S, Berrada M, Verhelst D, Donnadieu P, Moranne O, Esnault VL (2016) Vitamin E-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis: a multicenter, randomized, crossover trial. Am J Kidney Dis 68:752–762
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Funding
Funding for this study was provided by the Royal Free Hospital. Kamonwan Tangvoraphonkchai was in receipt of a scholarship from the International Society of Nephrology
Additional information
Answers
1. d; 2. b; 3. d; 4. a; 5. d
Rights and permissions
About this article
Cite this article
Tangvoraphonkchai, K., Davenport, A. Enhancing dialyser clearance—from target to development. Pediatr Nephrol 32, 2225–2233 (2017). https://doi.org/10.1007/s00467-017-3647-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-017-3647-y